Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Renal Cell | 6 | 2022 | 424 | 2.630 |
Why?
|
| Kidney Neoplasms | 6 | 2022 | 619 | 2.400 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2022 | 182 | 1.750 |
Why?
|
| Biomarkers, Tumor | 8 | 2024 | 1464 | 1.230 |
Why?
|
| Th2 Cells | 5 | 2017 | 146 | 1.170 |
Why?
|
| Dendritic Cells | 5 | 2015 | 425 | 1.050 |
Why?
|
| Receptors, IgG | 2 | 2014 | 52 | 0.930 |
Why?
|
| Eosinophils | 1 | 2020 | 194 | 0.700 |
Why?
|
| Mesothelioma | 4 | 2023 | 311 | 0.680 |
Why?
|
| Leiomyoma | 1 | 2022 | 191 | 0.680 |
Why?
|
| Interleukins | 4 | 2014 | 134 | 0.600 |
Why?
|
| Hypersensitivity | 2 | 2014 | 154 | 0.540 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 736 | 0.490 |
Why?
|
| Lectins, C-Type | 1 | 2014 | 85 | 0.480 |
Why?
|
| Inflammation | 4 | 2014 | 923 | 0.420 |
Why?
|
| Cell Differentiation | 2 | 2014 | 1458 | 0.390 |
Why?
|
| Mutation | 4 | 2024 | 3968 | 0.370 |
Why?
|
| Lung | 2 | 2013 | 1168 | 0.360 |
Why?
|
| Signal Transduction | 4 | 2014 | 3243 | 0.360 |
Why?
|
| Pleural Neoplasms | 2 | 2023 | 188 | 0.340 |
Why?
|
| Neoplasms | 1 | 2024 | 2898 | 0.330 |
Why?
|
| Blood Glucose | 1 | 2011 | 873 | 0.290 |
Why?
|
| Prognosis | 4 | 2024 | 3680 | 0.290 |
Why?
|
| Diabetes Mellitus | 2 | 2011 | 806 | 0.280 |
Why?
|
| Humans | 23 | 2024 | 86656 | 0.280 |
Why?
|
| Lung Neoplasms | 3 | 2023 | 2262 | 0.260 |
Why?
|
| Gastritis, Atrophic | 1 | 2023 | 3 | 0.240 |
Why?
|
| Interleukin-33 | 2 | 2014 | 24 | 0.240 |
Why?
|
| Genomics | 3 | 2024 | 720 | 0.240 |
Why?
|
| Gastritis | 1 | 2023 | 32 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 6 | 2017 | 3095 | 0.220 |
Why?
|
| Hypersensitivity, Immediate | 2 | 2013 | 62 | 0.220 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2023 | 43 | 0.220 |
Why?
|
| Peritoneal Neoplasms | 1 | 2023 | 177 | 0.210 |
Why?
|
| Neurofibromin 2 | 1 | 2022 | 30 | 0.210 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2022 | 27 | 0.210 |
Why?
|
| Middle Aged | 7 | 2023 | 25036 | 0.210 |
Why?
|
| Meningeal Neoplasms | 1 | 2022 | 61 | 0.210 |
Why?
|
| Lymphoma, T-Cell | 1 | 2022 | 48 | 0.210 |
Why?
|
| Meningioma | 1 | 2022 | 59 | 0.200 |
Why?
|
| Sarcoma | 1 | 2023 | 215 | 0.200 |
Why?
|
| Platelet Aggregation | 1 | 2021 | 44 | 0.200 |
Why?
|
| Asthma | 3 | 2015 | 955 | 0.200 |
Why?
|
| Formaldehyde | 1 | 2021 | 52 | 0.200 |
Why?
|
| Lymphoma, B-Cell | 1 | 2022 | 103 | 0.200 |
Why?
|
| Thrombin | 1 | 2021 | 61 | 0.200 |
Why?
|
| Keratin-20 | 1 | 2020 | 6 | 0.200 |
Why?
|
| Keratin-7 | 1 | 2020 | 10 | 0.200 |
Why?
|
| Vimentin | 1 | 2020 | 44 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 189 | 0.190 |
Why?
|
| Blood Platelets | 1 | 2021 | 149 | 0.190 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2023 | 456 | 0.190 |
Why?
|
| Cytokines | 2 | 2014 | 778 | 0.190 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 193 | 0.180 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2020 | 14 | 0.180 |
Why?
|
| Adenosine Triphosphate | 1 | 2021 | 314 | 0.180 |
Why?
|
| Immunohistochemistry | 2 | 2023 | 1753 | 0.180 |
Why?
|
| Leukemia | 1 | 2022 | 320 | 0.180 |
Why?
|
| Eosinophilia | 1 | 2020 | 84 | 0.180 |
Why?
|
| Female | 12 | 2023 | 44547 | 0.180 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2021 | 164 | 0.180 |
Why?
|
| Retrospective Studies | 3 | 2023 | 8495 | 0.170 |
Why?
|
| Male | 8 | 2023 | 40984 | 0.170 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 1 | 2017 | 18 | 0.150 |
Why?
|
| Necrosis | 1 | 2018 | 204 | 0.150 |
Why?
|
| Interleukin-5 | 1 | 2017 | 36 | 0.150 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2021 | 383 | 0.150 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 1056 | 0.140 |
Why?
|
| Acute Lung Injury | 1 | 2017 | 60 | 0.140 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 357 | 0.140 |
Why?
|
| Adult | 5 | 2023 | 25657 | 0.140 |
Why?
|
| Melanoma | 1 | 2020 | 459 | 0.130 |
Why?
|
| Liver | 1 | 2021 | 1228 | 0.130 |
Why?
|
| Mice, Knockout | 3 | 2017 | 1924 | 0.130 |
Why?
|
| Animals | 8 | 2017 | 26590 | 0.130 |
Why?
|
| Transcription Factors | 2 | 2014 | 1565 | 0.130 |
Why?
|
| Bone Marrow Cells | 2 | 2013 | 253 | 0.130 |
Why?
|
| Lymphocytes | 1 | 2017 | 464 | 0.130 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2017 | 165 | 0.130 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2014 | 11 | 0.130 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2014 | 12 | 0.130 |
Why?
|
| Receptors, Interleukin | 1 | 2014 | 35 | 0.120 |
Why?
|
| Mice | 5 | 2017 | 11356 | 0.120 |
Why?
|
| Antigen-Antibody Complex | 1 | 2014 | 87 | 0.120 |
Why?
|
| Immunization | 1 | 2014 | 158 | 0.120 |
Why?
|
| Lymphocyte Activation | 2 | 2014 | 728 | 0.120 |
Why?
|
| Th17 Cells | 1 | 2014 | 80 | 0.120 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 168 | 0.120 |
Why?
|
| Th1 Cells | 1 | 2014 | 164 | 0.120 |
Why?
|
| Food Hypersensitivity | 1 | 2014 | 63 | 0.120 |
Why?
|
| Monocytes | 1 | 2015 | 216 | 0.110 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2023 | 63 | 0.110 |
Why?
|
| Allergens | 1 | 2014 | 179 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 3642 | 0.110 |
Why?
|
| Interferon Regulatory Factors | 1 | 2013 | 67 | 0.110 |
Why?
|
| Young Adult | 2 | 2023 | 5980 | 0.110 |
Why?
|
| Immune Tolerance | 1 | 2015 | 337 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 196 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 376 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2014 | 715 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2013 | 679 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 456 | 0.100 |
Why?
|
| Bacteria | 1 | 2014 | 447 | 0.090 |
Why?
|
| Macrophages | 1 | 2013 | 557 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2438 | 0.090 |
Why?
|
| Career Choice | 1 | 2011 | 142 | 0.090 |
Why?
|
| Aged | 3 | 2023 | 18421 | 0.090 |
Why?
|
| Adolescent | 1 | 2020 | 8984 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 1169 | 0.070 |
Why?
|
| Crohn Disease | 1 | 2011 | 730 | 0.060 |
Why?
|
| Exodeoxyribonucleases | 1 | 2023 | 14 | 0.060 |
Why?
|
| Peritoneum | 1 | 2023 | 57 | 0.060 |
Why?
|
| Biology | 1 | 2023 | 50 | 0.060 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2023 | 33 | 0.060 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 1 | 2023 | 23 | 0.060 |
Why?
|
| DNA Helicases | 1 | 2023 | 79 | 0.060 |
Why?
|
| DNA Mismatch Repair | 1 | 2023 | 52 | 0.060 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 2022 | 10 | 0.050 |
Why?
|
| Phenotype | 2 | 2022 | 2380 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2011 | 1010 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2023 | 279 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 302 | 0.050 |
Why?
|
| Gene Fusion | 1 | 2021 | 38 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2021 | 54 | 0.050 |
Why?
|
| Platelet Count | 1 | 2021 | 92 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2022 | 506 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2023 | 6513 | 0.050 |
Why?
|
| Ipilimumab | 1 | 2020 | 58 | 0.050 |
Why?
|
| Biopsy | 1 | 2023 | 1163 | 0.040 |
Why?
|
| Intestines | 2 | 2014 | 411 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2021 | 302 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2020 | 117 | 0.040 |
Why?
|
| Cyclosporine | 1 | 2020 | 234 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 645 | 0.040 |
Why?
|
| Bleomycin | 1 | 2017 | 98 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 1921 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2018 | 580 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 861 | 0.030 |
Why?
|
| Clostridium | 1 | 2014 | 21 | 0.030 |
Why?
|
| Colony Count, Microbial | 1 | 2014 | 46 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2023 | 2271 | 0.030 |
Why?
|
| Dermatitis, Atopic | 1 | 2015 | 52 | 0.030 |
Why?
|
| Mites | 1 | 2013 | 16 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2014 | 510 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2013 | 149 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2819 | 0.030 |
Why?
|
| Osteopontin | 1 | 2011 | 47 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2011 | 164 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2014 | 409 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 373 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 689 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2231 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2014 | 669 | 0.020 |
Why?
|
| Data Collection | 1 | 2011 | 372 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 747 | 0.020 |
Why?
|
| Microbiota | 1 | 2014 | 381 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 1540 | 0.020 |
Why?
|
| Internal Medicine | 1 | 2011 | 349 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 1135 | 0.020 |
Why?
|
| Pediatrics | 1 | 2011 | 344 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 797 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 1195 | 0.020 |
Why?
|